铋中毒表现为活动能力下降和跌倒。
Bismuth Toxicity Presenting as Declining Mobility and Falls.
作者信息
Hogan David B, Harbidge Cathy, Duncan Amy
机构信息
Division of Geriatric Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
Calgary Fall Prevention Clinic, Specialized Geriatric Services, Alberta Health Services, Edmonton, AB, Canada.
出版信息
Can Geriatr J. 2018 Dec 30;21(4):307-309. doi: 10.5770/cgj.21.323. eCollection 2018 Dec.
Abstract
A 77-year old woman presented with a history of falls. Known health problems included biopsy-proven collagenous colitis treated with bismuth subsalicylate. On examination, in addition to impaired balance and gait, she was found to have tremors and cognitive deficits. Investigations revealed a markedly elevated urinary bismuth level. Withdrawal of bismuth subsalicylate led to marked cognitive and physical improvement.
摘要
一名77岁女性因跌倒史就诊。已知的健康问题包括经活检证实的胶原性结肠炎，曾用次水杨酸铋治疗。检查发现，除平衡和步态受损外，她还有震颤和认知缺陷。调查显示尿铋水平显著升高。停用次水杨酸铋后，认知和身体状况有明显改善。
相似文献
1
Bismuth Toxicity Presenting as Declining Mobility and Falls.
Can Geriatr J. 2018 Dec 30;21(4):307-309. doi: 10.5770/cgj.21.323. eCollection 2018 Dec.
2
Bismuth subsalicylate toxicity as a cause of prolonged encephalopathy with myoclonus.
Mov Disord. 1995 Mar;10(2):220-2. doi: 10.1002/mds.870100215.
3
Interventions for treating collagenous colitis.
Cochrane Database Syst Rev. 2004(1):CD003575. doi: 10.1002/14651858.CD003575.pub2.
4
Interventions for treating collagenous colitis.
Cochrane Database Syst Rev. 2002(4):CD003575. doi: 10.1002/14651858.CD003575.
5
Interventions for treating collagenous colitis.
Cochrane Database Syst Rev. 2003(1):CD003575. doi: 10.1002/14651858.CD003575.
6
Interventions for treating collagenous colitis.
Cochrane Database Syst Rev. 2003(3):CD003575. doi: 10.1002/14651858.CD003575.
7
[Treatment of collagenous colitis. An analysis of a systematic Cochrane review].
Ugeskr Laeger. 2003 Aug 11;165(33):3154-6.
8
Interventions for treating collagenous colitis.
Cochrane Database Syst Rev. 2006 Oct 18(4):CD003575. doi: 10.1002/14651858.CD003575.pub4.
9
Interventions for treating collagenous colitis.
Cochrane Database Syst Rev. 2005 Oct 19(4):CD003575. doi: 10.1002/14651858.CD003575.pub3.
10
Collagenous colitis treated successfully with bismuth subsalicylate.
Dig Dis Sci. 2000 Jul;45(7):1447-50. doi: 10.1023/a:1005584810298.
引用本文的文献
1
Bioactive Bismuth Compounds: Is Their Toxicity a Barrier to Therapeutic Use?
Int J Mol Sci. 2024 Jan 27;25(3):1600. doi: 10.3390/ijms25031600.
2
Diagnosis and Pharmacological Management of Microscopic Colitis in Geriatric Care.
Drugs Aging. 2024 Feb;41(2):113-123. doi: 10.1007/s40266-023-01094-6. Epub 2024 Jan 17.
3
Effectiveness of Non-Budesonide Therapies in Management of Microscopic Colitis: A Systematic Review and Meta-analysis.
Drugs. 2023 Jul;83(11):1027-1038. doi: 10.1007/s40265-023-01914-4. Epub 2023 Jun 26.
4
Clinical Values of Serum Uric Acid Levels in the Occurrence of Cognitive Impairment in Alcohol-Dependent Patients.
Alpha Psychiatry. 2023 Mar 1;24(2):43-48. doi: 10.5152/alphapsychiatry.2023.221065. eCollection 2023 Mar.
5
On the Biocompatibility and Teat Retention of In Situ Gelling Intramammary Formulations: Cattle Mastitis Prevention and Treatment.
Pharmaceutics. 2021 Oct 19;13(10):1732. doi: 10.3390/pharmaceutics13101732.
6
Simultaneous Dual-Contrast Imaging of Small Bowel With Iodine and Bismuth Using Photon-Counting-Detector Computed Tomography: A Feasibility Animal Study.
Invest Radiol. 2020 Oct;55(10):688-694. doi: 10.1097/RLI.0000000000000687.
7
Bismuth encephalopathy- a rare complication of long-standing use of bismuth subsalicylate.
BMC Neurol. 2019 Aug 29;19(1):212. doi: 10.1186/s12883-019-1437-9.
本文引用的文献
1
Current Approach to the Evaluation and Management of Microscopic Colitis.
Curr Gastroenterol Rep. 2017 Feb;19(2):8. doi: 10.1007/s11894-017-0551-3.
2
Chronic encephalopathy with ataxia, myoclonus, and auditory neuropathy: A case of bismuth poisoning.
Neurol India. 2017 Jan-Feb;65(1):186-187. doi: 10.4103/0028-3886.198185.
3
Diagnosis and Management of Microscopic Colitis.
Am J Gastroenterol. 2017 Jan;112(1):78-85. doi: 10.1038/ajg.2016.477. Epub 2016 Nov 29.
4
Contemporary methods for the diagnosis and treatment of microscopic colitis.
Expert Rev Gastroenterol Hepatol. 2016;10(1):47-61. doi: 10.1586/17474124.2016.1096197. Epub 2015 Oct 15.
5
Clinical characteristics and patterns and predictors of response to therapy in collagenous and lymphocytic colitis.
Scand J Gastroenterol. 2015;50(11):1382-8. doi: 10.3109/00365521.2015.1050692. Epub 2015 May 21.
6
Pepto bismuth associated neurotoxicity: A rare side effect of a commonly used medication.
W V Med J. 2013 May-Jun;109(3):32-4.
7
Microscopic colitis: Current status, present and future challenges: statements of the European Microscopic Colitis Group.
J Crohns Colitis. 2012 Oct;6(9):932-45. doi: 10.1016/j.crohns.2012.05.014. Epub 2012 Jun 15.
8
Management of chronic diarrhea in HIV-infected patients: current treatment options, challenges and future directions.
HIV AIDS (Auckl). 2010;2:219-24. doi: 10.2147/HIV.S13191. Epub 2010 Nov 10.
9
Interventions for treating collagenous colitis.
Cochrane Database Syst Rev. 2008 Apr 16(2):CD003575. doi: 10.1002/14651858.CD003575.pub5.
10
Collagenous colitis treated successfully with bismuth subsalicylate.
Dig Dis Sci. 2000 Jul;45(7):1447-50. doi: 10.1023/a:1005584810298.
Zotero 插件